USPTO serial 99696100
PROSCIENTO THE METABOLIC CONTINUUM CRO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- MARCY, AMY ALFIERI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with PROSCIENTO THE METABOLIC CONTINUUM CRO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Chula Vista, CA, US
Chula Vista, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer Heisler Lavalley
Jennifer Heisler Lavalley GTC Law Group PC & AffiliatesOne University Avenue, Suite 302BWestwood, MA 02090United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting and project management in the fields of clinical trials and metabolic health, namely, providing information management services; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes and management of clinical trial execution by providing independent review of clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, management of clinical trial execution; providing technical consulting services in the field of marketing and advertising for clinical trials, verifying clinical trial subject eligibility for clinical trials, clinical trial subject recruitment and enrollment for clinical trials, and processing business documents relating to clinical trials, and information management services, namely, clinical data management to medical, pharmaceutical and technology companies in order to assist them with clinical research, clinical trials and applications for drug approval; compilation of statistics and clinical trial data for business purposes; statistical analysis for business purposes; preparing and placing advertisements for others, namely, to recruit subjects for participation in clinical trials; providing referrals of subjects for enrollment in clinical trials | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 20, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 20, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 14, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 21, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 21, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 21, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 21, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 21, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 29, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 29, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 29, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 14, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 14, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 14, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 11, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 9, 2026 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jul 9, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 11, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 11, 2026 | NWAP | NEW APPLICATION ENTERED | — |